News & Events

Ketan Patel has over two decades of experience driving innovation at the intersection of data, AI, and life sciences. Most recently, he served as VP of Product Management at Clarivate, shaping solutions that support pharmaceutical R&D and evidence-based decision-making. Prior to this, Ketan held senior product leadership roles at AstraZeneca, Oracle, Pfizer, and Eli Lilly, where he led the creation of digital platforms and tools designed to accelerate and de-risk drug discovery and development.

Ketan Patel has over two decades of experience driving innovation at the intersection of data, AI, and life sciences. Most recently, he served as VP of Product Management at Clarivate, shaping solutions that support pharmaceutical R&D and evidence-based decision-making. Prior to this, Ketan held senior product leadership roles at AstraZeneca, Oracle, Pfizer, and Eli Lilly, where he led the creation of digital platforms and tools designed to accelerate and de-risk drug discovery and development.

Ketan Patel has over two decades of experience driving innovation at the intersection of data, AI, and life sciences. Most recently, he served as VP of Product Management at Clarivate, shaping solutions that support pharmaceutical R&D and evidence-based decision-making. Prior to this, Ketan held senior product leadership roles at AstraZeneca, Oracle, Pfizer, and Eli Lilly, where he led the creation of digital platforms and tools designed to accelerate and de-risk drug discovery and development.

Jean-Philippe Vert is the Co-Founder and CEO of Bioptimus, an AI-first company building foundation models to accelerate breakthroughs in biology and medicine. A global authority on AI for life sciences, he previously served as Chief R&D Officer at Owkin, Research Lead at Google Brain, and held academic positions at ENS Paris, the Curie Institute, Mines ParisTech, and UC Berkeley. He holds degrees from École Polytechnique and the Corps des Mines, and a PhD in mathematics from Paris University.

Jean-Philippe Vert is the Co-Founder and CEO of Bioptimus, an AI-first company building foundation models to accelerate breakthroughs in biology and medicine. A global authority on AI for life sciences, he previously served as Chief R&D Officer at Owkin, Research Lead at Google Brain, and held academic positions at ENS Paris, the Curie Institute, Mines ParisTech, and UC Berkeley. He holds degrees from École Polytechnique and the Corps des Mines, and a PhD in mathematics from Paris University.

Jean-Philippe Vert is the Co-Founder and CEO of Bioptimus, an AI-first company building foundation models to accelerate breakthroughs in biology and medicine. A global authority on AI for life sciences, he previously served as Chief R&D Officer at Owkin, Research Lead at Google Brain, and held academic positions at ENS Paris, the Curie Institute, Mines ParisTech, and UC Berkeley. He holds degrees from École Polytechnique and the Corps des Mines, and a PhD in mathematics from Paris University.

Eight internationally renowned experts join Bioptimus to pioneer large-scale foundation models that will transform science and medicine

Eight internationally renowned experts join Bioptimus to pioneer large-scale foundation models that will transform science and medicine

Ketan Patel and Tokuwa Kanno bring deep user, product, and scientific expertise to accelerate real-world applications of Bioptimus’ foundation model for biology.

Ketan Patel and Tokuwa Kanno bring deep user, product, and scientific expertise to accelerate real-world applications of Bioptimus’ foundation model for biology.

Industry veteran brings deep expertise in biotech commercialization and pharma partnerships to advance foundation model for biology

Industry veteran brings deep expertise in biotech commercialization and pharma partnerships to advance foundation model for biology

Through DGX Cloud Lepton and collaboration with Sofinnova Partners, Bioptimus gains critical AI infrastructure to scale biological model training

Through DGX Cloud Lepton and collaboration with Sofinnova Partners, Bioptimus gains critical AI infrastructure to scale biological model training

The official announcement was made today by Clara Chappaz, Minister for Digital Affairs and Artificial Intelligence.

The official announcement was made today by Clara Chappaz, Minister for Digital Affairs and Artificial Intelligence.

This launch gives healthcare and life sciences organizations immediate access to deploy Bioptimus’s cutting-edge pathology model in their own secure cloud environments.

This launch gives healthcare and life sciences organizations immediate access to deploy Bioptimus’s cutting-edge pathology model in their own secure cloud environments.

We have recently released H-Optimus-1, a new foundation model (FM) for pathology.

We have recently released H-Optimus-1, a new foundation model (FM) for pathology.

Mathilda joins Bioptimus with an extensive track record in building pioneering businesses and a reputation as a leader in scaling impactful organizations globally.

Mathilda joins Bioptimus with an extensive track record in building pioneering businesses and a reputation as a leader in scaling impactful organizations globally.

We are proud to launch Bioptimus. Our company mission? To create and build the first universal AI foundational model for biology.

We are proud to launch Bioptimus. Our company mission? To create and build the first universal AI foundational model for biology.

Creating the first and only Foundation model for biology

Creating the first and only Foundation model for biology

Bioptimus will connect the different scales of biology with generative AI

Bioptimus will connect the different scales of biology with generative AI